A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus
Condition(s):Respiratory Syncytial VirusLast Updated:February 26, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Respiratory Syncytial VirusLast Updated:February 26, 2024Active, not recruiting
Condition(s):Overactive BladderLast Updated:March 2, 2020Completed
Condition(s):Depression; Bipolar I DisorderLast Updated:March 7, 2024Recruiting
Condition(s):Schizophrenia; Bipolar I Disorder; Autism Spectrum Disorder (ASD)Last Updated:March 6, 2024Recruiting
Condition(s):Prevention of Esophageal Varices; NASH – Nonalcoholic Steatohepatitis; CirrhosisLast Updated:November 9, 2023Active, not recruiting
Condition(s):Uterine FibroidsLast Updated:May 3, 2023Terminated
Condition(s):Uterine FibroidsLast Updated:February 26, 2024Active, not recruiting
Condition(s):Herpes Labialis; Cold SoreLast Updated:November 2, 2021Completed
Condition(s):Cardiovascular DiseaseLast Updated:July 11, 2018Terminated
Condition(s):Cardiovascular DiseaseLast Updated:May 1, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.